ARTIVION INC (AORT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AORT - US2289031005 - Common Stock
43.25 USD
-0.82 (-1.86%)
43.25 USD
0 (0%)
AORT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. AORT has an average financial health and profitability rating. AORT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
AORT had negative earnings in the past year.
In the past year AORT had a positive cash flow from operations.
AORT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of AORT (-1.06%) is better than 71.66% of its industry peers.
The Return On Equity of AORT (-2.08%) is better than 71.66% of its industry peers.
AORT has a Return On Invested Capital of 2.28%. This is in the better half of the industry: AORT outperforms 69.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROIC | 2.28% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT has a better Operating Margin (5.26%) than 70.59% of its industry peers.
In the last couple of years the Operating Margin of AORT has grown nicely.
AORT has a Gross Margin of 64.50%. This is in the better half of the industry: AORT outperforms 65.78% of its industry peers.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
The number of shares outstanding for AORT has been increased compared to 1 year ago.
The number of shares outstanding for AORT has been increased compared to 5 years ago.
AORT has a worse debt/assets ratio than last year.
2.2 Solvency
AORT has an Altman-Z score of 3.78. This indicates that AORT is financially healthy and has little risk of bankruptcy at the moment.
AORT's Altman-Z score of 3.78 is fine compared to the rest of the industry. AORT outperforms 73.80% of its industry peers.
The Debt to FCF ratio of AORT is 12.48, which is on the high side as it means it would take AORT, 12.48 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.48, AORT is in the better half of the industry, outperforming 72.19% of the companies in the same industry.
AORT has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.50, AORT perfoms like the industry average, outperforming 42.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Altman-Z | 3.78 |
ROIC/WACC0.27
WACC8.46%
2.3 Liquidity
A Current Ratio of 3.93 indicates that AORT has no problem at all paying its short term obligations.
The Current ratio of AORT (3.93) is better than 67.91% of its industry peers.
AORT has a Quick Ratio of 2.88. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.88, AORT is doing good in the industry, outperforming 64.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 |
3. Growth
3.1 Past
AORT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.71%.
The Revenue has grown by 9.81% in the past year. This is quite good.
AORT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.06% yearly.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.17% yearly.
The Revenue is expected to grow by 11.94% on average over the next years. This is quite good.
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AORT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 93.99 indicates a quite expensive valuation of AORT.
AORT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AORT is cheaper than 66.31% of the companies in the same industry.
AORT is valuated expensively when we compare the Price/Forward Earnings ratio to 23.52, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 93.99 |
4.2 Price Multiples
AORT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AORT is cheaper than 66.84% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AORT is valued a bit cheaper than 69.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 117.07 | ||
| EV/EBITDA | 48.5 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 53.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.22%
EPS Next 3Y53.35%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
43.25
-0.82 (-1.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.11%
Inst Owner ChangeN/A
Ins Owners4.19%
Ins Owner Change-6.39%
Market Cap2.05B
Revenue(TTM)422.65M
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (21.97%)
Short Float %2.93%
Short Ratio3.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)14.27%
PT rev (3m)21.97%
EPS NQ rev (1m)22.44%
EPS NQ rev (3m)-8.95%
EPS NY rev (1m)86.52%
EPS NY rev (3m)81.82%
Revenue NQ rev (1m)0.93%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 93.99 | ||
| P/S | 4.85 | ||
| P/FCF | 117.07 | ||
| P/OCF | 67.26 | ||
| P/B | 4.67 | ||
| P/tB | 73.55 | ||
| EV/EBITDA | 48.5 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.46
Fwd EY1.06%
FCF(TTM)0.37
FCFY0.85%
OCF(TTM)0.64
OCFY1.49%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROCE | 2.88% | ||
| ROIC | 2.28% | ||
| ROICexc | 2.52% | ||
| ROICexgc | 6.11% | ||
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% | ||
| FCFM | 4.14% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 56.35% | ||
| Cap/Sales | 3.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 | ||
| Altman-Z | 3.78 |
F-Score5
WACC8.46%
ROIC/WACC0.27
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year115.81%
EBIT Next 3Y44.55%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 5 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 6 / 10.